Blood Test Shows Promise in Spotting Preeclampsia Before Symptoms Surface
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
TUESDAY, July 16, 2024 -- An experimental blood test could help detect pregnant women at increased risk for preeclampsia, a serious high blood pressure condition that can harm both mother and child.
Researchers report the test looks at genetic markers found in tiny particles called extracellular vesicles that transfer information between human cells.
Women with preeclampsia followed a specific pattern of these genetic markers compared to women with healthy pregnancies, results showed.
This pattern can form as early as the first trimester of pregnancy, researchers said, and it has the potential to predict the development of preeclampsia symptoms.
Preeclampsia usually occurs after week 20 of pregnancy, and it affects 5% to 8% of all pregnancies, according to the American Pregnancy Association.
The condition can cause liver or kidney failure in pregnant women and increase their future risk of heart disease. If left untreated, preeclampsia can cause stroke, seizures and excessive bleeding in the mother and contribute to low birth weight in newborns.
“It is critical that we take steps toward early detection and prevention of preeclampsia,” said lead researcher Dr. Sherin Devaskar, executive chair of pediatrics at UCLA Mattel Children’s Hospital.
“It continues to be the leading cause of maternal mortality and morbidity worldwide, and our findings underscore the potential to address this persistent public health concern,” Devaskar added in a UCLA news release.
For the study, published July 16 in the journal Scientific Reports, researchers looked at 14 women with symptoms of preeclampsia, 12 women with healthy pregnancies and seven women who weren’t pregnant.
Blood tests revealed specific microRNA patterns in pregnant women with preeclampsia. MicroRNAs are short RNA molecules that regulate the function of genes.
Specifically, pregnant women with preeclampsia had 12 microRNAs in higher amounts and 135 in lower amounts, compared to healthy pregnant women.
This pattern could help doctors flag women at risk for preeclampsia and get them early treatment, researchers said. It also could help improve understanding of why preeclampsia occurs in some women.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-16 21:15
Read more
- Flu-Linked Hospitalization Rates Vary Across Seasons, Highest in Adults 65+
- FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer
- Vitamin D Supplements Could Help Lower Blood Pressure in Obese People
- Topical Human Platelet Extract Noninferior for Photoaging of Hands
- PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions